A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor
- PMID: 22188926
- DOI: 10.1124/mol.111.075937
A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor
Abstract
The recent publication of both the antagonist- and agonist-bound structures of the adenosine A(2A) receptor have revealed much about how a ligand may bind to a receptor and cause the conformational changes associated with agonist-mediated activation. In particular, the agonist-bound structure revealed key interactions between the ribose group of adenosine-derived agonists and amino acids in the receptor binding pocket that lead to receptor activation. However, agonists without a ribose group also exist, and we wondered whether such compounds occupy the same agonist binding site. Therefore we used a mutagenesis approach in this study to investigate the mode of binding of 2-amino-4-(4-hydroxyphenyl)- 6-(1H-imidazol-2-ylmethylsulfanyl)pyridine-3,5-dicarbonitrile (LUF5834), a potent partial agonist without a ribose moiety, compared with the adenosine-derived reference agonist 2-[p-(2-carboxyethyl)phenyl-ethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680). Mutation of the orthosteric residue Phe168 to alanine abrogated the function of both agonists. However, mutation to alanine of residues Thr88 and Ser277 shown by the crystal structures to interact with the ribose group of adenosine-like ligands had no effect on the potency of LUF5834. Furthermore, alanine mutation of Asn253, which makes a hydrogen-bonding interaction with the exocyclic nitrogen of the adenine ring, had minimal effect on LUF5834 affinity but removed agonist activity of this ligand. Mutation of other residues, such as the highly conserved Trp246 or Glu13, had significant deleterious effects on the function of CGS21680 but little effect on LUF5834. In summary, our findings suggest that this class of agonist interacts with distinct residues to activate the receptor compared with classic adenosine derived agonists.
Similar articles
-
Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.Biochem Pharmacol. 2010 Oct 15;80(8):1180-9. doi: 10.1016/j.bcp.2010.06.041. Epub 2010 Jun 30. Biochem Pharmacol. 2010. PMID: 20599769
-
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.J Med Chem. 2004 Jul 15;47(15):3707-9. doi: 10.1021/jm049947s. J Med Chem. 2004. PMID: 15239649
-
A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.Mol Pharmacol. 1994 May;45(5):861-70. Mol Pharmacol. 1994. PMID: 8190103
-
Ligand-specific binding and activation of the human adenosine A(2B) receptor.Biochemistry. 2013 Jan 29;52(4):726-40. doi: 10.1021/bi3012065. Epub 2013 Jan 14. Biochemistry. 2013. PMID: 23286920
-
Structure-affinity relationships of adenosine A2B receptor ligands.Med Res Rev. 2006 Sep;26(5):667-98. doi: 10.1002/med.20069. Med Res Rev. 2006. PMID: 16847822 Review.
Cited by
-
Sodium ion binding pocket mutations and adenosine A2A receptor function.Mol Pharmacol. 2015 Feb;87(2):305-13. doi: 10.1124/mol.114.095737. Epub 2014 Dec 3. Mol Pharmacol. 2015. PMID: 25473121 Free PMC article.
-
Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.Mol Pharmacol. 2015 Jun;87(6):907-15. doi: 10.1124/mol.114.097360. Epub 2015 Mar 11. Mol Pharmacol. 2015. PMID: 25762024 Free PMC article.
-
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.Pharmaceuticals (Basel). 2019 Oct 8;12(4):150. doi: 10.3390/ph12040150. Pharmaceuticals (Basel). 2019. PMID: 31597388 Free PMC article. Review.
-
Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.PLoS Comput Biol. 2021 Nov 24;17(11):e1009152. doi: 10.1371/journal.pcbi.1009152. eCollection 2021 Nov. PLoS Comput Biol. 2021. PMID: 34818333 Free PMC article.
-
Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors.Molecules. 2017 Nov 10;22(11):1945. doi: 10.3390/molecules22111945. Molecules. 2017. PMID: 29125553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources